Cortechs.ai – a leading pioneer in developing AI-powered brain image analysis solutions for several neurological disorders, the company recently announced the acquisition of San Diego-based Zepmed. Zepmed is the developer of imaging software solutions aimed to improve radiology analyses. This acquisition well complements Cortech’s core capabilities and will help amplify their position in the marketplace. (Highlighted in July 2025)

ecoATM – a global leader in developing automated kiosks to easily recycle and buy-back mobile phones and other electronic devices, the company recently announced the launch of its kiosks in the Canadian marketplace, brought about by a strategic partnership with Walmart. Initial locations will be within a limited number of Walmart stores in the Greater Toronto Area with eventual plans for further expansion across Canada. (Highlighted in December 2024)

Fuse Integration – a leader in developing innovative communications solutions for our nation’s warfighters, this service-disabled, veteran-owned company was recently recognized with the highest honor – Platinum level – with the 2025 Technology Innovators Award by Military + Aerospace Electronics for their Tactical Edge Network solution, an innovative software solution. (Highlighted in September 2025)

Inhibrx – a clinical stage biotech company developing cancer and rare disease therapeutics, they recently announced very positive Phase-2 trial results with their lead candidate, ozekibart, in a rare bone cancer for which there are currently no approved treatments. These encouraging results may lead the company to seek approval from the U.S. Food and Drug Administration (FDA) next year. (Highlighted in March 2025)

MyoGene Bio – an early-stage biotech company developing gene editing therapies to treat muscle diseases, the company was recently awarded two grants- one from the National Institute of Child Health and Human Development (NICHD), and the other from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH). (Highlighted in July 2025)

Nano PharmaSolutions – is a biotech company which has developed a delivery technology that generates drug nanoparticles to enhance the bioavailability and uptake of insoluble drugs. In partnership with Atlanta-based CDMO, Mikart, LLC, they recently announced positive results from a Phase-1 clinical trial, currently in progress, for their NT-301, a powder nasal spray for treating Parkinson’s disease OFF episodes. (Highlighted in November 2022)

Resolute Science – is a pre-clinical biotech company whose mission is to develop pan-cancer therapeutics to treat aggressive and hard-to-treat solid tumors. The company was recently granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for its lead candidate, RS-5, designed for treatment of soft tissue sarcomas. (Highlighted in March 2025)